Trial intelligence / Profile preview

DRI Trial of glycopyrronium versus hyoscine for drooling in children

ISRCTN75287237Phase 4Completed

Sponsor
Newcastle Hospitals NHS Foundation Trust
Start
Sep 2013
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01

Overview

Phase 4, randomised trial in hypersalivation comparing Glycopyrronium with Hyoscine (2 arms). Primary endpoint: Drooling Impact Scale score at 4 weeks. Started Sep 2013; status: completed.

02

Drugs

glycopyrroniumscopolamine
03

Conditions

hypersalivation

Beyond the preview

Go deeper on ISRCTN75287237.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN75287237.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call